Home Urinalysis Reagent Strips Microalbumin Creatinine Test Strips

Rapid Response™ Urine Analyzer - an efficient and accurate tool for interpreting Rapid Response™ Urinalysis Reagent Strips results. Read, store, and print results in under 2 minutes.

Urinalysis
CLIA Waived
Microalbumin Creatinine Test Strips
U2.3-1S25
For Point-of-Care Use
For Professional Use Only
25 Tests / Kit
Need help? Contact our support or sales team.
Product Code: U2.3-1S25
Sample: Urine
Format: Strip
Quantity: 25 Tests / Kit
Sensitivity: Albumin 150mg/L, Creatinine 300mg/dL
Specificity: Microalbumin & Creatinine
Time to result: within 2 minutes
Storage Condition: 36-86°F/2-30°C
Test Principle: Colorimetric Analysis
Contents
Description

The Rapid Response™ Urinalysis Reagent Strips (Microalbumin/Creatinine) is intended for the semi semiquantitative measurement of albumin (and creatinine (CRE) in urine. For use with the Rapid Response™ U120S Urine Analyzer. Results are used to aid in the diagnosis of kidney function. This test is for professional use only. For use at the point of care. Positive results should be confirmed with quantitative method.

Compatible with the Rapid Response Urine Analyzer U120. To learn more, visit the U121S product page.

Features
About the Test
What is a urine test
How does it work (visual read)
How does it work (UA-U121S)
What’s measured
Microalbuminuria & Creatinine
Proficiency Testing from CAP
Resources
References
  1. Nisell, H. et al: Renal Function in Gravidas with Chronic Hypertension With and Without Superimposed Preeclampsia. J. Hypertens. Pregnancy 15: 127-134; 1996.
  2. Burtis, C.A. and Ashwood, E.R.: Tietz Textbook of Clinical Chemistry , 3rd ed. Philadelphia: Saunders; 1999; pp. 483-484.
  3. Mangili, R. et al.: Prevalence of Hypertension and Microalbuminuria in Adult Type 1 (Insulin-Dependent) Diabetic patients Without Renal Failure in Italy-Validation of Screening Techniques to Detect Microalbuminuria. Acta Diabetol . 29: 156-166; 1992.
  4. American Diabetes Association, Clinical Practice Recommendations, Diabetes Care, Vol. 31, Suppl. 1, January 2008.
  5. Position Statement: Diabetic Nephropathy. Diabetes Care 20: S24-S27; 1997.
Disclaimer
  • Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
  • The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
  • Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.